The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
It is only experience in the markets in which you learn market mechanics. The newbies on this board you have to understand that market makers make money off volumes and liquidity (making a market), a static share price will not help them. Apart from the £2m trade which could have been a buy or a sell there equilibrium of buys and sells in the last few days did not warrant a 25% drop in share price. It is clear it was artificial (praying on uncertainty) to take out stop losses and leveraged traders, for those that got caught short, please remember this can happen in the future.
£2 was an obvious bottom on the chart due to the gap, let’s hope this was the line in the sand. It certainly looks like fomo has kicked back in and surprise surprise bullish momentum is back. If no RNS then certainly ‘I wouldn’t want to be out of this over the long weekend’ applies.
Win, Win. Well done to those who held and added, I certainly did and am f***ing excited as to where this will now head.
False - Which own test? Would he really be saying this if it was their own test.
Use common sense.
"We look forward to receiving notification of which test will be produced under this arrangement and we will update shareholders as these tests move towards production and purchase orders are received."
I wonder who this could be - writing is now well and truly on the wall
"In addition, the Company still awaits confirmation that a COVID-19 lateral flow antigen test has passed the necessary performance evaluation. Accordingly, there are no COVID-19 lateral flow antigen tests that can be manufactured by Omega, on behalf of the Government, at this time.
As soon as the DHSC has access to a test that has successfully passed performance evaluation, it will be licensed to Omega for manufacture. When the test is ready for production Omega expects to receive purchase orders from the DHSC for these tests and, where appropriate, the Company will make further statements given that these production volumes are expected to result in substantial revenue growth for new financial year."
Indeed, as per ODX tweet a few weeks ago you'd expect them to RNS this as would imagine will give further details of the test they are manufacturing. Perhaps accompanied with something from Avacta if it is indeed this test.
Either way looks like we are now in a position to start releasing more details of this long awaited story.
I am not sure what the purpose of the second interview would be but he must have two enormous pieces of news which would have to be digested over two separate days!
Loving this new PR rollout- its so close
I am not sure anyone in their right mind would short but ballsy if so.
I think its more a case of those knowing the opportunity was there and are kicking themselves for not buying in sooner and deramping trying to get a better entry.
Anyone who spends as much time on this board (GKB - I have them blocked but seems like they are still posting) would know that the ducks are being aligned here and news on many fronts is due soon. Numerous top posters have highlighted this and so thank you for the continued developments in the story.
Anyway onwards we forget about the deramps. Should be a good week building into expected news towards the end of the month. I am not expecting THE RNS quite yet but would not be surprised if it came earlier that we think. A steady rise over the next couple of weeks will form a higher base for when we get to take off day.
Have not been this excited and committed (% of portfolio) to a share in my 7 years of investing.